ARGATRACOR

Welcome to the Brand page for “ARGATRACOR”, which is offered here for Pharmaceutical products for use as an anticoagulant and for the treatment of heparin-induced thrombocytopenia with or without thrombosis, acute coronary syndromes, ischemic stroke, percutaneous coronary interventions, venous thrombosis, arterial thrombosis, coagulopathies, pulmonary embolism, peripheral embolism and hemodialysis;.

Its status is currently believed to be active. Its class is unavailable. “ARGATRACOR” is believed to be currently owned by “Texas Biotechnology Corporation”.


Owner:
TEXAS BIOTECHNOLOGY CORPORATION
Owner Details
Description:
Pharmaceutical products for use as an anticoagulant and for the treatment of heparin-induced thrombocytopenia with or without thrombosis, acute coronary syndromes, ischemic stroke, percutaneous coronary interventions, venous thrombosis, arterial thrombosis, coagulopathies, pulmonary embolism, peripheral embolism and hemodialysis;
Categories: PHARMACEUTICAL PRODUCTS USE AS